PHARMING GRP SP. ADRS (PHG) — Cash Flow Quality Index
PHARMING GRP SP. ADRS (PHG) has a Cash Flow Quality Index of 2.01x as of December 2025. Operating cash flow of €10.71 Million exceeds net income of €5.33 Million, indicating high earnings quality where cash backs reported profits. Explore PHG strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PHARMING GRP SP. ADRS Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for PHARMING GRP SP. ADRS across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of PHARMING GRP SP. ADRS to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year earnings quality comparison for PHARMING GRP SP. ADRS. For live market cap and the full company financial profile, see market cap of PHARMING GRP SP. ADRS.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 19.19x | €54.71 Million | €2.85 Million | ▲ +1068.4% |
| 2022 | 1.64x | €22.46 Million | €13.67 Million | ▼ -36.9% |
| 2021 | 2.60x | €37.84 Million | €14.54 Million | — |